Life sciences companies and doctors can leverage Veeva CRM Engage Meeting BARCELONA, Spain \u2014 22 Jul, 2020<\/strong> \u2014 Veeva Systems<\/a> (NYSE: VEEV) today announced it is bringing Veeva CRM Engage Meeting<\/a> functionality to Zoom and Microsoft Teams. Now customers will have greater flexibility and choice in how they conduct remote meetings and connect with healthcare professionals (HCPs).<\/p>\n \u201cOur open approach gives the life sciences industry the freedom to use Veeva software the way that works best for them and meets their needs,\u201d said Arno Sosna, general manager of Veeva CRM<\/a>. \u201cCustomers will have more options in how they leverage Veeva CRM Engage Meeting and collaborate with doctors that may already be using Zoom and Microsoft Teams.\u201d<\/p>\n Seamless integration with Zoom and Microsoft Teams enables customers to benefit from the same innovative functionality in Veeva CRM Engage Meeting across any platform. Companies can use remote sampling to capture HCP product sample requests; remote medical inquiry management to compliantly respond to HCP medical inquiries; and remote consent for HCPs to approve their communication preferences remotely.<\/p>\n Veeva CRM Engage Meeting makes online meetings with healthcare providers easy and compliant. The application is free for life sciences companies through December 2020 so they can stay connected with HCPs as in-person access remains limited during COVID-19. Integration with Zoom and Microsoft Teams is planned for availability in January 2021.<\/p>\n In other news today, Veeva announced that Syneos Health is offering biopharmaceutical customers Veeva Commercial Cloud<\/a> solutions to speed commercial launches. Read today\u2019s press release<\/a> for more information.<\/p>\n To learn more about Veeva CRM Engage Meeting, visit: veeva.com\/EngageMeeting<\/a>.<\/p>\n Additional Information<\/strong> About Veeva Systems<\/strong> Forward-looking Statements<\/strong> ###<\/p>\n
across the online meeting platforms they\u2019re already using<\/em><\/p>\n
\nConnect with Veeva on LinkedIn: linkedin.com\/company\/veeva-systems<\/a>
\nFollow @veeva_eu on Twitter: twitter.com\/veeva_eu<\/a>
\nLike Veeva on Facebook: facebook.com\/veevasystems<\/a><\/p>\n
\nVeeva Systems Inc. is the leader in cloud-based software for the global life sciences industry. Committed to innovation, product excellence, and customer success, Veeva serves more than 875 customers, ranging from the world\u2019s largest pharmaceutical companies to emerging biotechs. Veeva is headquartered in the San Francisco Bay Area, with offices throughout North America, Europe, Asia, and Latin America. For more information, visit veeva.com\/eu<\/a>.<\/p>\n
\nThis release contains forward-looking statements, including the market demand for and acceptance of Veeva\u2019s products and services, the results from use of Veeva\u2019s products and services, and general business conditions (including the on-going impact of COVID-19), particularly within the life sciences industry. Any forward-looking statements contained in this press release are based upon Veeva\u2019s historical performance and its current plans, estimates, and expectations, and are not a representation that such plans, estimates, or expectations will be achieved. These forward-looking statements represent Veeva\u2019s expectations as of the date of this press announcement. Subsequent events may cause these expectations to change, and Veeva disclaims any obligation to update the forward-looking statements in the future. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially. Additional risks and uncertainties that could affect Veeva\u2019s financial results are included under the captions, \u201cRisk Factors\u201d and \u201cManagement\u2019s Discussion and Analysis of Financial Condition and Results of Operations,\u201d in the company\u2019s filing on Form 10-Q for the period ended April 30, 2020. This is available on the company\u2019s website at veeva.com<\/a> under the Investors section and on the SEC\u2019s website at sec.gov<\/a>. Further information on potential risks that could affect actual results will be included in other filings Veeva makes with the SEC from time to time.<\/p>\n